Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

BJC reports·2026
Same author

Machine learning, whole genome sequencing, and Mendelian randomization support a role of CRP on COVID-19 severity.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

BJC reports·2026
Same author

A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors.

Journal of medicinal chemistry·2026
Same author

From comprehensive geriatric assessment to rapid bedside screening: comparing MPI and BRASS in predicting hospital outcomes in older adults - the S. Giovanni-Addolorata Hospital-SIGOT GRACE study.

BMC geriatrics·2026
Same author

Multi-parametric profiling of plasma-derived extracellular vesicles reveals a disease-associated molecular signature supporting a liquid biopsy approach in myelofibrosis.

Molecular medicine (Cambridge, Mass.)·2026

Related Experiment Videos

How can prognosis for diabetic ESRD be improved?

Francesco Locatelli1, Lucia Del Vecchio, Andrea Cavalli

  • 1Department of Nephrology and Dialysis, Ospedale A. Manzoni, Via dell'Eremo 9, 23900 Lecco, Italy. nefrologia@ospedale.lecco.it

Seminars in Dialysis
|March 10, 2010
PubMed
Summary

Patients with diabetes undergoing renal replacement therapy (RRT) face worse outcomes due to cardiovascular issues. Advanced hemodialysis and peritoneal dialysis offer comparable short-term results for managing end-stage renal disease (ESRD) in diabetics.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Diabetology
  • Cardiovascular Medicine

Background:

  • Patients with diabetes undergoing renal replacement therapy (RRT) have poorer survival and rehabilitation rates than non-diabetics, primarily due to cardiovascular complications.
  • The nephrology community employs multifaceted approaches to optimize treatment for diabetic patients with end-stage renal disease (ESRD).

Purpose of the Study:

  • To review current treatment options and challenges for diabetic patients on RRT.
  • To compare the efficacy and complications of hemodialysis and peritoneal dialysis in this population.

Main Methods:

  • Review of recent data on hemodialysis (HD) and peritoneal dialysis (PD) for diabetic ESRD patients.
  • Analysis of clinical problems associated with HD, including vascular access and intradialytic hypotension.
  • Assessment of PD-related complications like increased peritoneal permeability and fibrosis in diabetics.

Main Results:

  • Hemodialysis, the most common RRT for diabetics, presents challenges like vascular access management and intradialytic hypotension.
  • Efficient high-flux hemodialysis and sodium profiling may improve outcomes and reduce hypotension in diabetic ESRD patients.
  • Peritoneal dialysis in diabetics is associated with accelerated peritoneal membrane deterioration, leading to technique failure, though short-term outcomes are comparable to HD.

Conclusions:

  • Despite improvements, diabetic ESRD patients on RRT face significant challenges, particularly cardiovascular complications.
  • Optimized hemodialysis strategies, including high-flux and sodium profiling, show promise for improving morbidity and mortality.
  • While peritoneal dialysis faces specific long-term complications in diabetics, both modalities offer comparable short-term results.